Cyprus vs Yemen: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cyprus
0.5%
in 2024
Yemen
0.5%
in 2024
Cyprus rank
56th
Yemen rank
56th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cyprus
- Yemen
How they compare
Cyprus currently reports 0.5% against 0.5% in Yemen, a difference of 0.0%.
Across all 10 years both countries report, Yemen has been ahead every year.
Cyprus ranks 56th and Yemen ranks 56th of 215 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.0% | Yemen |
| 2020s | 0.5% | 0.5% | 0.0% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cyprus or Yemen?
- Cyprus, at 0.5% against 0.5% in Yemen as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cyprus and Yemen?
- 0.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Yemen?
- 10 years are reported by both, from 2015 to 2024.
- How do Cyprus and Yemen rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cyprus ranks 56th and Yemen ranks 56th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.